What are the special considerations for vaccination in multiple sclerosis (MS)?

Updated: Oct 08, 2019
  • Author: Christopher Luzzio, MD; Chief Editor: Jasvinder Chawla, MD, MBA  more...
  • Print

Some special considerations for vaccination in MS patients from the National Multiple Sclerosis Society are as follows [48] :

  • In patients experiencing a serious relapse that affects their ability to carry out activities of daily living, defer vaccination until 4-6 weeks after the onset of the relapse

  • Vaccine response may be blunted in patients who have received immune globulin in the past 3 months or who are taking natalizumab or fingolimod.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!